Aberdeen Group Files Schedule 13G/A for Corbus Pharmaceuticals
Aberdeen Group filed a Schedule 13G/A related to Corbus Pharmaceuticals.
Related stories
MTAR Technologies Reports Q2 Revenue of ₹406.8 Crore, Up 200% Year on Year
MTAR Technologies reported Q2 FY27 revenue from operations of ₹406.8 crore, up 200% year on year. Shares gained after the results.
M impact | EQUITY | Oct 30, 2026, 03:51 AM UTC
Milky Mist shares rise after quarterly results
M impact | EQUITY | Oct 30, 2026, 03:51 AM UTC
India's Trent shares rise 6.34% as fashion sales and margins improve
Trent shares rose 6.34% to 3,041.10 rupees on Friday after the apparel retailer reported higher second-quarter profit, improving existing-store sales and stronger margins.
M impact | EQUITY | Oct 30, 2026, 03:48 AM UTC
Borosil shares rise 7% after quarterly profit increase
Borosil Ltd shares are up 7% after quarterly profit rose.
M impact | EQUITY | Oct 30, 2026, 03:47 AM UTC
Steamhouse India shares fall 7.82% in pre-open trade
Shares fell 7.82% in pre-open trading after quarterly results.
M impact | EQUITY | Oct 30, 2026, 03:43 AM UTC
Garware Technical Fibres shares rise 4.42% in pre-open trade
Garware Technical Fibres shares are up 4.42% in pre-open trade on a quarterly profit jump.
M impact | EQUITY | Oct 30, 2026, 03:42 AM UTC